Industry to publish all Phase III trials in peer-reviewed journals
This article was originally published in SRA
The International Federation of Pharmaceutical Manufacturers and Associations and its members have committed to submitting the results of all industry-sponsored Phase III clinical trials for publication in scientific peer-reviewed journals. However, Germany’s health technology appraisal institute, IQWiG, said that the IFPMA’s bid to improve transparency does not go far enough to prevent publication bias.
You may also be interested in...
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.